130 related articles for article (PubMed ID: 34689564)
21. Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism.
Jové M; Gatius S; Yeramian A; Portero-Otin M; Eritja N; Santacana M; Colas E; Ruiz M; Pamplona R; Matias-Guiu X
Oncotarget; 2016 Aug; 7(32):52364-52374. PubMed ID: 27429042
[TBL] [Abstract][Full Text] [Related]
22. Metabolomics reveals metabolite changes of patients with pulmonary arterial hypertension in China.
Chen C; Luo F; Wu P; Huang Y; Das A; Chen S; Chen J; Hu X; Li F; Fang Z; Zhou S
J Cell Mol Med; 2020 Feb; 24(4):2484-2496. PubMed ID: 31945804
[TBL] [Abstract][Full Text] [Related]
23. A systematic review of metabolomic profiling of gastric cancer and esophageal cancer.
Huang S; Guo Y; Li Z; Zhang Y; Zhou T; You W; Pan K; Li W
Cancer Biol Med; 2020 Feb; 17(1):181-198. PubMed ID: 32296585
[No Abstract] [Full Text] [Related]
24. Identification of six candidate genes for endometrial carcinoma by bioinformatics analysis.
Zhu Y; Shi L; Chen P; Zhang Y; Zhu T
World J Surg Oncol; 2020 Jul; 18(1):161. PubMed ID: 32641130
[TBL] [Abstract][Full Text] [Related]
25. Lipid metabolic dysregulation is involved in Parkinson's disease dementia.
Dong MX; Wei YD; Hu L
Metab Brain Dis; 2021 Mar; 36(3):463-470. PubMed ID: 33433787
[TBL] [Abstract][Full Text] [Related]
26. Development and Validation of a Five-immune Gene Pair Signature in Endometrial Carcinoma.
Li N; Yu K; Lin Z; Zeng D
Comb Chem High Throughput Screen; 2021; 24(2):233-245. PubMed ID: 32729416
[TBL] [Abstract][Full Text] [Related]
27. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
[TBL] [Abstract][Full Text] [Related]
28. Identification and functional analyses of differentially expressed metabolites in early stage endometrial carcinoma.
Shi K; Wang Q; Su Y; Xuan X; Liu Y; Chen W; Qian Y; Lash GE
Cancer Sci; 2018 Apr; 109(4):1032-1043. PubMed ID: 29436067
[TBL] [Abstract][Full Text] [Related]
29. Metabolomics study of the therapeutic mechanism of a Chinese herbal formula on collagen-induced arthritis mice.
Jin Z; Zhang JD; Wu X; Cao G
RSC Adv; 2019 Jan; 9(7):3716-3725. PubMed ID: 35518061
[TBL] [Abstract][Full Text] [Related]
30. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
Liang Q; Wang C; Li B
Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
[TBL] [Abstract][Full Text] [Related]
31. Development and Validation of a Serum Metabolomic Signature for Endometrial Cancer Screening in Postmenopausal Women.
Troisi J; Raffone A; Travaglino A; Belli G; Belli C; Anand S; Giugliano L; Cavallo P; Scala G; Symes S; Richards S; Adair D; Fasano A; Bottigliero V; Guida M
JAMA Netw Open; 2020 Sep; 3(9):e2018327. PubMed ID: 32986110
[TBL] [Abstract][Full Text] [Related]
32. Metabolome-based signature of disease pathology in MS.
Andersen SL; Briggs FBS; Winnike JH; Natanzon Y; Maichle S; Knagge KJ; Newby LK; Gregory SG
Mult Scler Relat Disord; 2019 Jun; 31():12-21. PubMed ID: 30877925
[TBL] [Abstract][Full Text] [Related]
33. Competing endogenous RNA network of endometrial carcinoma: A comprehensive analysis.
Liu J; Nie S; Liang J; Jiang Y; Wan Y; Zhou S; Cheng W
J Cell Biochem; 2019 Sep; 120(9):15648-15660. PubMed ID: 31056798
[TBL] [Abstract][Full Text] [Related]
34. High-throughput metabolomics investigates anti-osteoporosis activity of oleanolic acid via regulating metabolic networks using ultra-performance liquid chromatography coupled with mass spectrometry.
Xu Y; Chen S; Yu T; Qiao J; Sun G
Phytomedicine; 2018 Dec; 51():68-76. PubMed ID: 30466629
[TBL] [Abstract][Full Text] [Related]
35. A Multi-Omics Approach Revealed Common Dysregulated Pathways in Type One and Type Two Endometrial Cancers.
Capaci V; Monasta L; Aloisio M; Sommella E; Salviati E; Campiglia P; Basilicata MG; Kharrat F; Licastro D; Di Lorenzo G; Romano F; Ricci G; Ura B
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003247
[TBL] [Abstract][Full Text] [Related]
36. TMEFF2 is a novel prognosis signature and target for endometrial carcinoma.
Gao L; Nie X; Zheng M; Li X; Guo Q; Liu J; Liu Q; Hao Y; Lin B
Life Sci; 2020 Feb; 243():116910. PubMed ID: 31610211
[TBL] [Abstract][Full Text] [Related]
37. Identification of Metabolomic Biomarkers for Endometrial Cancer and Its Recurrence after Surgery in Postmenopausal Women.
Audet-Delage Y; Villeneuve L; Grégoire J; Plante M; Guillemette C
Front Endocrinol (Lausanne); 2018; 9():87. PubMed ID: 29593653
[TBL] [Abstract][Full Text] [Related]
38. Tumor stiffness measured by 3D magnetic resonance elastography can help predict the aggressiveness of endometrial carcinoma: preliminary findings.
Zhang L; Long X; Nijiati M; Zhang T; Li M; Deng Y; Kuang S; Xiao Y; Zhu J; He B; Chen J; Rossman P; Glaser KJ; Venkatesh SK; Ehman RL; Wang J
Cancer Imaging; 2021 Aug; 21(1):50. PubMed ID: 34454623
[TBL] [Abstract][Full Text] [Related]
39. Liquid Chromatography-Mass Spectrometry-Based Tissue Metabolic Profiling Reveals Major Metabolic Pathway Alterations and Potential Biomarkers of Lung Cancer.
You L; Fan Y; Liu X; Shao S; Guo L; Noreldeen HAA; Li Z; Ouyang Y; Li E; Pan X; Liu T; Tian X; Ye F; Li X; Xu G
J Proteome Res; 2020 Sep; 19(9):3750-3760. PubMed ID: 32693607
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
